A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...
Approximately 100 times faster, will accelerate solutions for drug discovery, finance, and other complex problems~ Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts ...
Toshiba developed a breakthrough third‑generation simulated bifurcation algorithm that dramatically boosts SBM performance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results